Ardelyx director granted stock and options
ARDELYX, INC. director David M. Mott reported equity awards under the company’s Non-Employee Director Compensation Program.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ARDELYX, INC. director David M. Mott reported equity awards under the company’s Non-Employee Director Compensation Program. He received two grants of Common Stock totaling 46,737 shares at no cash cost and a stock option for 39,715 shares at an exercise price of $5.67 per share, expiring on June 16, 2036. Footnotes explain that some shares are held for entities associated with New Enterprise Associates and that restricted stock units and the option vest over time, with acceleration tied to the next annual stockholders’ meeting.
Insider Trade Summary
Grant/Award: 86,452 shares
Grant/Award
3 txns
Insider
MOTT DAVID M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 39,715 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 20,282 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 26,455 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 39,715 contracts (Direct);
Common Stock — 3,349,655 shares (Direct)
Footnotes (5)
- F1. The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.
- F2. The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.
- F3. Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.
- F4. The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
- F5. The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.
Key Figures
Stock award 1: 26,455 shares
Stock award 2: 20,282 shares
Option grant size: 39,715 options
+3 more
6 metrics
Stock award 1
26,455 shares
Common Stock grant on June 16, 2026
Stock award 2
20,282 shares
Common Stock grant on June 16, 2026
Option grant size
39,715 options
Stock option (right to buy) on June 16, 2026
Option exercise price
<money>$5.67</money> per share
Stock option for Ardelyx Common Stock
Option expiration
<date>June 16, 2036</date>
Expiration date of director stock option
Shares held for NEA entities
87,566 shares
Shares held for entities associated with New Enterprise Associates
Key Terms
Non-Employee Director Compensation Program, Restricted stock units ("RSUs"), pecuniary interest, stock option, +1 more
5 terms
Non-Employee Director Compensation Program financial
"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program."
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
pecuniary interest financial
"disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein."
stock option financial
"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Ardelyx (ARDX) director David M. Mott report?
David M. Mott reported equity awards, not open-market trades. He received two grants of Ardelyx Common Stock totaling 46,737 shares and a stock option for 39,715 shares, all as part of the Non-Employee Director Compensation Program.
Were David M. Mott’s Ardelyx (ARDX) transactions open-market purchases or sales?
The transactions were equity awards, not market trades. All three entries use code A for grants or awards, with zero purchase price, indicating compensation-related acquisitions instead of open-market buying or selling of Ardelyx shares.
What are the key terms of David M. Mott’s new Ardelyx stock option?
Mott received a stock option covering 39,715 Ardelyx shares at an exercise price of $5.67 per share. The option was granted under the Non-Employee Director Compensation Program and expires on June 16, 2036, with vesting over time as described in footnotes.
How do the Ardelyx RSUs granted to David M. Mott work?
The filing notes that restricted stock units entitle Mott to one Ardelyx Common Share for each RSU when it vests. These RSUs were issued under the Non-Employee Director Compensation Program and vest according to the plan’s schedule before converting into common stock.
How does the Ardelyx director stock option granted to David M. Mott vest?
The option vests in equal monthly installments. One-twelfth of the shares vest on each monthly anniversary of the grant date, with any remaining unvested portion vesting fully on the date of the next annual stockholders’ meeting, subject to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
